ArticleBioengineering (Basel, Switzerland)2021
Biocompatible Customized 3D Bone Scaffolds Treated with CRFP, an Osteogenic Peptide.
Article in Bioengineering (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 11 citations in OpenAlex.
- Synthetic 3D printed tibial plateau with gradient material properties for biomechanical accuracy.Frontiers in bioengineering and biotechnology · 2025Article
- Digital neurosurgery in the era of intelligent medicine: a scoping review.Frontiers in medicine · 2025Review
- Sophisticated Study of Time, Frequency and Statistical Analysis for Gradient-Switching-Induced Potentials during MRI.Bioengineering (Basel, Switzerland) · 2023Article
- Medical 3D printing with polyjet technology: effect of material type and printing orientation on printability, surface structure and cytotoxicity.3D printing in medicine · 2023Article
- Semi-Supervised Medical Image Segmentation with Co-Distribution Alignment.Bioengineering (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCurrently used synthetic bone graft substitutes (BGS) are either too weak to bear the principal load or if metallic, they can support loading, but can lead to stress shielding and are unable to integrate fully. In this study, we developed biocompatible, 3D printed scaffolds derived from µCT images of the bone that can overcome these issues and support the growth of osteoblasts.
methodsCylindrical scaffolds were fabricated with acrylonitrile butadiene styrene (ABS) and Stratasys
resultsFor the ABS scaffolds, there was a 9.8% increase in compressive strength (
conclusionsMED610 scaffolds are excellent BGS as they support osteoblast growth and show enhanced bone growth with enhanced compressive strength when augmented with CRFP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.